Associations of anxiety and depression with prognosis in chronic obstructive pulmonary disease: A systematic review and meta-analysis
Top Cited Papers
Open Access
- 13 December 2024
- journal article
- review article
- Published by Taylor & Francis in Pulmonology
- Vol. 31 (1) , 2438553
Abstract
The associations between anxiety, depression, and the prognosis of COPD remain uncertain. The present study aims to investigate the associations of anxiety and depression with 30-day readmission rates and acute exacerbations of COPD (AECOPD). Four databases were searched to identify relevant studies published before 13 March 2024. Studies that report on the impact of anxiety and depression on the prognosis of AECOPD were included. The pooled effect size and its 95% confidence interval (CI) were calculated using a random effects model. The primary outcomes were 30-day readmission and AECOPD within the first year after discharge in COPD patients. Of the 5,955 studies screened, 14 studies were included in the analysis. Patients with anxiety had a higher risk of AECOPD within the first year after discharge compared to those without anxiety (HR: 2.10, 95% CI: 1.28-3.45, p = 0.003). Patients with depression also had a higher risk of AECOPD within the first year after discharge (HR: 1.36, 95% CI: 1.10-1.69, p = 0.004). Similar results were observed in the associations of anxiety and depression with 30-day readmission. Our results suggested that anxiety and depression were associated with an increased risk of 30-day readmission and AECOPD in patients with COPD.Keywords
Funding Information
- Foundation of Guangzhou National Laboratory (SRPG22-018 and SRPG22-016)
- Natural Science Foundation of China (81970045)
- Natural Science Foundation of China (81970038)
- Natural Science Foundation of China (82270043)
- the Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease (SKLRD-L-202402)
- Project of Guangzhou Medical University’s Scientific Research Capability Improvement Plan (GMUCR2024-01012)
- Guangzhou Science and Technology Plans (202201020372)
This publication has 66 references indexed in Scilit:
- Examining the contribution of Notch signaling to lung disease developmentNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Manejo clínico de la EPOC en situación de vida real. Análisis a partir de big dataArchivos de Bronconeumología, 2021
- The Role of Early Life Stress in HPA Axis and Anxiety2020
- The Hospital Anxiety and Depression Scale (HADS) and the 9‐item Patient Health Questionnaire (PHQ‐9) as screening instruments for depression in patients with cancerCancer, 2017
- Pharmacological Treatment of Depression in Older Patients with Chronic Obstructive Pulmonary Disease: Impact on the Course of the Disease and Health OutcomesDrugs & Aging, 2014
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Depressive Symptoms and Chronic Obstructive Pulmonary DiseaseArchives of internal medicine (1960), 2007
- Anxious and depressive disorders and their comorbidity: Effect on central nervous system noradrenergic functionBiological Psychiatry, 2004
- What's the Relative Risk?JAMA, 1998
- A Self-Rating Depression ScaleArchives of General Psychiatry, 1965